Live Breaking News & Updates on Medical Oncology Department

Stay updated with breaking news from Medical oncology department. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lurbinectedin Plus Irinotecan Is Safe, Prolongs Responses in High-Risk, Pretreated SCLC

Clinical benefit generated from treatment with lurbinectedin plus irinotecan was noted across sensitive and resistant patient populations with SCLC. ....

Luisg Paz , Oncology Department , Medical Oncology Department , Hospital Universitario , Universidad Complutense De Madrid ,

Neoadjuvant Sacituzumab Govitecan Displays Activity in Muscle-Invasive Bladder Cancer, But Questions Remain

Neoadjuvant sacituzumab govitecan demonstrated efficacy in patients with muscle-invasive bladder cancer, but its future role in the space is uncertain. ....

Thomas Powles , Antonio Cigliola , Oncology Department , Barts Cancer Centre At St , Medical Oncology Department , Raffaele Hospital , Genitourinary Oncology , Barts Cancer Centre ,

Ipatasertib/Anti-HER2 Therapy Is Safe and Active in PIK3CA-Mutant, HER2+ Advanced Breast Cancer

Ipatasertib plus trastuzumab and pertuzumab as frontline maintenance therapy was effective and safe in PIK3CA-mutant, HER2-positive advanced breast cancer. ....

Comunidad Autonoma De Cataluna , Israel General , Daiichi Sankyo Astrazeneca , Mafalda Oliveira , Breast Cancer Congress , Hebron University Hospital , Breast Cancer Group , Hebron Institute Of Oncology , Oncology Department Of The Breast Cancer Group , Ayala Pharmaceuticals , Medical Oncology Department , University Hospital , Hebron Institute , Zenith Epigenetics , Cureos Science , Relay Therapeutics ,

Olaparib/Durvalumab/Fulvestrant Combo Meets PFS End Point in HRR-Altered or MSI ER+/HER2– Breast Cancer

Olaparib/Durvalumab/Fulvestrant Combo Meets PFS End Point in HRR-Altered or MSI ER+/HER2– Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Oncology Department , Breast Cancer Annual Congress , Montpellier Cancer Institute , Cancer Annual Congress , Medical Oncology Department ,

J&J: positive CHMP opinion for lung cancer

J&J: positive CHMP opinion for lung cancer
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Nicolas Girard , Institut Curie , Head Of The Medical Oncology Department , Professor Nicolas Girard , Medical Oncology Department , Thoracic Oncology , Respiratory Medicine , Paris Saclay ,